REGENXBIO Share Price

REGENXBIO Share Price

NASDAQ: RGNX | Small Cap | Healthcare
$7.16
-$0.01 (-0.14%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

REGENXBIO Stock Performance

Open
$7.17
Prev. Close
$7.17
Circuit Range
N/A
Day Range
$6.90 - $7.30
Year Range
$5.46 - $16.19
Volume
54,773
Average Traded
$7.11

REGENXBIO Share Price Today

As of 21 November 2026, REGENXBIO Inc.'s share price is $7.16. The stock opened at $7.17, compared to its previous close of $7.17. During today's trading session, REGENXBIO Inc.'s share price traded between $6.90 and $7.30, with an average price of $7.10. Over the past 52 weeks, the stock has recorded a high of $16.19 and a low of $5.46. In terms of performance, REGENXBIO Inc.'s share price has risen by 1.85% over the last six months and is down 46.49% on a year-on-year basis.

REGENXBIO Share Price Chart

Line chart of the REGENXBIO price trend over the selected period. The price fell overall, ranging from 6.88 to 7.30, ending at 7.16.
$6.90$7.30
L
Show Current Price
H

REGENXBIO Stock Fundamentals & Key Indicators

Market Cap
$369.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.65
Revenue (TTM)
$170.44B
Return On Equity (TTM)
-118.36%
Profit Margin
-113.75%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
39.33%

REGENXBIO Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$30.34$6.39$108.02$9.16
Net Profit-$67.15-$90.05$22.71-$40.74
Net Profit Margin-221.32%-1409.23%21.02%-444.76%
Income ChangeN/A-34.10%125.22%-279.39%

REGENXBIO Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$112.72$90.24$83.33$170.44
Net Profit-$280.32-$263.49-$227.10-$193.88
Net Profit Margin-248.69%-291.99%-272.53%-113.75%
Income ChangeN/A6.00%13.81%14.63%

REGENXBIO Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets171.75187.99239.0417.29
Current Assets281.28278.0334.97415.98
Total Assets453.03465.99573.97833.27
Non Current Liabilities232.2103.14131.96186.64
Current Liabilities118.1103.19130.27130.43
Total Liabilities350.3206.34262.23317.07
Shareholders' Equity102.73259.65311.74516.2

REGENXBIO Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-123.96-173.13-218.41-207.49
Investing-15.87103.45190.94-11.93
Financing116.7792.68-34.97-28.84

About REGENXBIO

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

REGENXBIO Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.19
$7.16
-0.21%
Oct 2026
$7.50
$7.17
-4.65%
Sep 2026
$9.53
$7.52
-19.66%
Aug 2026
$9.79
$9.36
-3.31%
Jul 2026
$12.11
$9.68
-19.13%
Jun 2026
$6.92
$11.97
+70.27%
May 2026
$8.97
$7.03
-21.71%
Apr 2026
$8.78
$8.98
+7.29%
Mar 2026
$8.70
$8.37
-7.46%
Feb 2026
$10.95
$9.04
-18.84%
Jan 2026
$14.23
$11.14
-22.74%
Dec 2025
$12.53
$14.43
+7.81%

REGENXBIO Share Price FAQs